Soft targets: Nurses and the pharmaceutical industry

PLoS Medicine

Volumn 5, Issue 2, 2008, Pages 0193-0198

  Jutel, Annemarie ^a   Menkes, David B ^b  

^a OTAGO POLYTECHNIC   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; HEALTH CARE; INTERVIEW; MEDICAL EDUCATION; NURSE; NURSE PRACTITIONER; NURSING; NURSING EDUCATION; NURSING STUDENT; PATIENT EDUCATION; PRESCRIPTION; QUESTIONNAIRE; REVIEW; SEMI STRUCTURED INTERVIEW; VOCATIONAL EDUCATION; ECONOMICS; ETHICS; HUMAN; MARKETING; MEDICAL ETHICS; METHODOLOGY;

DRUG INDUSTRY; ETHICS, NURSING; HUMANS; MARKETING; NURSES;

EID: 39849089800     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050005     Document Type: Review

References (66)

1. Nursing Standard (2007) 'Special projects' sponsorship. Available: http://www.nursingstandard.co.uk/advertising/specprods.asp. Accessed 27 December 2007.
2. Burns D (2002) Nurse prescribing. Nurses' influence on GPs' prescribing. Nurs Times 98: 41-42.
3. Mansfield PR, Mintzes B, Richards D, Toop L (2005) Direct to consumer advertising. BMJ 330: 5-6.
4. Mansfield PR, Mintzes B (2003) Direct-to-consumer advertising is more profitable if it is misleading. N Z Med J 116: U610.
5. Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, et al. (2002) Influence of direct-to-consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. BMJ 324: 278-279.
6. Healy D (2006) The latest mania: Selling bipolar disorder. PLoS Med 3: e185. doi:10.1371/journal.pmed.0030185
7. Wazana A (2000) Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA 283: 373-380.
8. Smith R (2003) Medical journals and pharmaceutical companies: uneasy bedfellows. BMJ 326: 1202-1205.
9. Smith R (2002) Making progress with competing interests - still some way to go. BMJ 325: 1375-1376.
10. Baker C, Johnsrud MT, Crismon M, Rosenheck RA, Woods SW (2003) Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 183: 498-506.
11. Boyd EA, Bero LA (2000) Assessing faculty financial relationships with industry: a case study. JAMA 284: 2209-2214.
12. Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1176.
13. Moncrieff J, Hopker S, Thomas P (2005) Psychiatry and the pharmaceutical industry: who pays the piper? Psych Bull 29: 84-85.
14. Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, et al. (2005) Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162: 1957-1960.
15. Wager E (2003) How to dance with porcupines: rules and guidelines on doctors' relations with drug companies. BMJ 326: 1196-1198.
16. Gøtzsche PC, Hróbjartsson A, Johansen HK, Haahr MT, Altman DG, et al. (2007) Ghost authorship in industry-initiated randomised trials. PLoS Med 4: e19. doi:10.1371/journal.pmed.0040019
17. Menkes DB (2006) Psychiatrist subscribing preferences and attitudes toward promotion. Inaugural Conference on Disease-Mongering; 11-13 April 2006; Newcastle, Australia.
18. Ashmore R, Carver N (2001) The pharmaceutical industry and mental health nursing. Br J Nurs 10: 1396-1402.
19. Mahon S (2006) Impact of direct-to-consumer advertising on healthcare providers and consumers. Clin J Oncol Nurs 10: 417-420.
20. Viale PH (2003) What nurse practitioners should know about direct-to-consumer advertising of prescription medications. J Am Acad Nurse Pract 15: 297-304.
21. Inlander C (1991) A hard pill to swallow. Advertising prescription drugs directly to the consumer. Nurs Econ 9: 343-347.
22. Gruber W, Llewelyn J, Arras C, Lion S (1995) The role of the pharmaceutical industry in promoting patient education. Patient Educ Couns 26: 245-249.
23. Viale PH (2002) Direct-to-consumer advertising of prescription medications: implications for patients with cancer. Oncol Nurs Forum 29: 505-513.
24. Viale PH, Yamamoto DS (2004) The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications. Oncol Nurs Forum 31: 777-783.
25. Bowron A (2006) Bridging the information gap in primary care. Community Pract 79: 242.
26. Davies J, Hemingway S (2006) Pharmaceutical influences: nurse prescribers: eyes wide open. Nurse Prescr 1: e42.
27. DeSilets LD (2006) Commercial support for professional development. J Contin Educ Nurs 37: 52-53.
28. Edmunds M (2004) Confusing ethical guidelines dampen pharmaceutical support. Nurse Pract 29: 16.
29. Flewell MN (2006) Pharmaceutical sales reps: Value beyond samples. Adv Nurse Pract 14: 18.
30. Hall J, Cantrill J, Noyce P (2003) The information sources used by community nurse prescribers. Br J Nurs 12: 810-818.
31. Kessenich CR, Westbrook MH (1999) Pharmaceutical companies and the prescriptive practices of nurse practitioners. J Am Acad Nurse Pract 11: 533-538.
32. Monaghan MS, Galt KA, Turner PD, Houghton BL, Rich EC, et al. (2003) Student understanding of the relationship between the health professions and the pharmaceutical industry. Teaching and learning in medicine. 15: 14-20.
33. Nolan P, Carr N, Doran M (2004) Nurse prescribing: The experiences of psychiatric nurses in the United States. Nurs Stand 18: 33-38.
34. Young M (2006) They are more than just pretty people handing out cool pens. Dermatol Nurs 18: 323-324.
35. Klein CA (2006) Dispensing pharmaceutical samples: A few reminders. Nurse Pract 31: 15.
36. Alexander-Banys B (2002) Pharmaceutical company advertising practices: Call to arms. J Pediatr Health Care 16: 49-50.
37. Sidiqi S, Edmunds M (2003) Pharmaceutical influence? Nurse Pract 28: 6-7.
38. Edmunds M (2003) Response to Sidiqi. Nurse Pract 28: 7.
39. O'Malley P (2006) Pharmaceutical advertising and clinical nurse specialist practice. Clin Nurse Spec 20: 13-15.
40. Ashmore R, Carver N, Banks D (2007) Mental health nursing students' relationships with the pharmaceutical industry. Nurse Educ Today 27: 551-560.
41. Willis J (1997) The drug squad. Nurs Times 93: 36-38.
42. Day L (2006) Industry gifts to healthcare providers: are the concerns serious? Am J Crit Care 5: 510-513.
43. Liefer D (1997) Warning over drug courses. Nurs Stand 11: 9.
44. Kmietowicz Z (2004) Drug company influence extends to nurses, pharmacists and patient groups. BMJ 329: 1206.
45. Crigger NJ, Bennison JW (2006) Unethical marketing or business as usual? Adv Nurse Pract 15: 61-68.
46. Hemingway S (2003) Mental health nursing and the pharmaceutical industry. Ment Health Pract 7: 22-23.
47. Castledine G (2003) Nurses must be immune to product promotions. Br J Nurs 12: 827.
48. Stokamer CI (2003) Pharmaceutical gift giving: Analysis of an ethical dilemma. J Nurs Adm 33: 48-51.
49. Crigger NJ (2005) Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: The undiscovered country. J Am Acad Nurse Pract 17: 207-212.
50. International Committee of Medical Journal Editors (2007) Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication. Available: http://www.icmje.org/index.html. Accessed 27 December 2007.
51. Mansfield PR, Lexchin J, Wen LS, Grandori L, McCoy CP, et al. (2006) Educating health professionals about drug and device promotion: Advocates' recommendations. PLoS Med 3: e451. doi:10.1371/journal.pmed.0030451
52. Menkes DB (2006) Calling the piper's tune. Prim Care Clin Psychiatry 11: 147-149.
53. Cardarelli R, Licciardone JC, Taylor LG (2006) A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true? BMC Fam Pract 7: 13.
54. Ziegler M, Lew P, Singer B (1995) The accuracy of drug information from pharmaceutical sales representatives. JAMA 273: 1296-1298.
55. Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS (2003) The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med 18: 294-297.
56. Kaphingst KA, DeJong W (2004) Market watch: The educational potential of direct-to-consumer prescription drug advertising. Health Aff 23: 143-150.
57. Madhavan S, Amonkar MM, Elliot D, Burke K, Gore P (1997) The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther 22: 207-215.
58. Steinman M, Shlipak M, McPhee SJ (2001) Of principles and pens; attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med: 551-557.
59. Watkins RS, Kimberly J Jr (2004) What residents don't know about physician-pharmaceutical industry interactions. Acad Med 79: 432-437.
60. Emanuel EJ, Emanuel LL (1992) Four models of the physician-patient relationship. JAMA 267: 2221-2226.
61. Mansfield PR (2007) Is it insulting to suggest that health professionals are influenced by drug companies? Available: http://www.healthyskepticism.org/ news/2007/May.php. Accessed 27 December 2007.
62. Stanford University (2006) Policy and guidelines for interactions between the Stanford University School of Medicine, the Stanford Hospital and Clinics and Lucile Packard Children's Hospital with the pharmaceutical, bioetch, medical device, and hospital and research and supplies industries ("Industry" ). Available: http://med.stanford.edu/coi/siip/documents/siip_policy_aug06.pdf. Accessed 27 December 2007.
63. Jones M (2004) Case Report. Nurse prescribing: a case study in policy influence. Journal of nursing management. 12: 266-272.
64. Mittman DE, Yackeren TF, Hendrix P, Mirotznik HG (1994) Sales reps recognize value of nurse practitioners. Med Mark Media 29: 52-54.
65. Arnold M (2004) The hidden prescribers. Med Mark Media 39: 44-52.
66. While AE, Biggs KS (2004) Benefits and challenges of nurse prescribing. J Adv Nurs 45: 559-567.